Sumitomo Mitsui Financial Group, Inc. Gilead Sciences, Inc. Transaction History

Sumitomo Mitsui Financial Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $16,217 - $20,322	-280 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $15,571 - $17,673	-240 Reduced 46.15%	280 $21,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $35,198 - $37,975	520 New	520 $37,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $13,256 - $15,104	-234 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $14,531 - $18,270	234 New	234 $14,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $164,340 - $180,769	-2,667 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $166,714 - $184,023	2,667 New	2,667 $168,000
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $75,790 - $84,990	-1,225 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $76,599 - $85,811	1,225 New	1,225 $78,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $78,702 - $102,700	-1,300 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $92,664 - $102,596	1,300 New	1,300 $100,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $45,889 - $55,944	-630 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $44,824 - $52,617	630	630 $46,000

1,902

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Financial Group, Inc. with notifications on news.